Depletion of Ly6G/C+ cells ameliorates delayed cerebral vasospasm in subarachnoid hemorrhage

Journal of Neuroimmunology

Volumn 232, Issue 1-2, 2011, Pages 94-100

  Provencio, J Javier ^a   Altay, Tamer ^b   Smithason, Saksith ^a   Moore, Shari Korday ^a   Ransohoff, Richard M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Delayed cerebral vasospasm; Inflammation; Myeloid cells; Neutrophils; Subarachnoid hemmorhage

Indexed keywords

LYMPHOCYTE ANTIBODY;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW DEPRESSION; BRAIN DAMAGE; BRAIN VASOSPASM; CELL ACTIVATION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE ASSOCIATION; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE;

ANIMALS; ANTIGENS, LY; CELL SEPARATION; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MIDDLE CEREBRAL ARTERY; MYELOID CELLS; NEUTROPHILS; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 79952243780     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.10.016     Document Type: Article

References (24)

1. Altay T., Smithason S., Volokh N., Rasmussen P.A., Ransohoff R.M., Provencio J.J. A novel method for subarachnoid hemorrhage to induce vasospasm in mice. J. Neurosci. Meth. 2009, 183:136-140.
2. Baldwin M.E., Macdonald R.L., Huo D., Novakovic R.L., Goldenberg F.D., Frank J.I., Rosengart A.J. Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome. Stroke 2004, 35:2506-2511.
3. Clark J.F., Sharp F.R. Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 2006, 26:1223-1233.
4. Daley J.M., Thomay A.A., Connolly M.D., Reichner J.S., Albina J.E. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 2008, 83:64-70.
5. Dhar R., Diringer M.N. The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocrit. Care 2008, 8:404-412.
6. Gallia G.L., Tamargo R.J. Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage. Neurol. Res. 2006, 28:750-758.
7. Kurizaki T., Abe M., Sanderson S.D., Enke C.A., Baranowska-Kortylewicz J. Role of polymorphonuclear leukocytes, nitric oxide synthase, and cyclooxygenase in vascular permeability changes induced by C5a agonist peptides. Mol. Cancer Ther. 2004, 3:85-91.
8. Lin C.-L., Dumont A.S., Calisaneller T., Kwan A.-L., Hwong S.-L., Lee K.S. Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm. Surg. Neurol. 2005, 64:201-205. (discussion 205-6).
9. Ma C.X., Yin W.N., Cai B.W., He M., Wu J., Wang J.Y., Zeng Y., Ding J.L., You C. Toll-like receptor 4/nuclear factor-kappa B signaling detected in brain after early subarachnoid hemorrhage. Chin. Med. J. (Engl). 2009, 122(13):1575-1581.
10. Manno E.M., Gress D.R., Ogilvy C.S., Stone C.M., Zervas N.T. The safety and efficacy of cyclosporine A in the prevention of vasospasm in patients with Fisher grade 3 subarachnoid hemorrhages: a pilot study. Neurosurgery 1997, 40:289-293.
11. Mesis R.G., Wang H., Lombard F.W., Yates R., Vitek M.P., Borel C.O., Warner D.S., Laskowitz D.T. Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage. Neurosurg. Focus 2006, 21:E4.
12. Naruko T., Ueda M., Haze K., van der Wal A.C., van der Loos C.M., Itoh A., Komatsu R., Ikura Y., Ogami M., Shimada Y., Ehara S., Yoshiyama M., Takeuchi K., Yoshikawa J., Becker A.E. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002, 106:2894-2900.
13. Nguyen H.X., O'Barr T.J., Anderson A.J. Polymorphonuclear leukocytes promote neurotoxicity through release of matrix metalloproteinases, reactive oxygen species, and TNF-alpha. J. Neurochem. 2007, 102:900-912.
14. Oruckaptan H.H., Caner H.H., Kilinc K., Ozgen T. No apparent role for neutrophils and neutrophil-derived myeloperoxidase in experimental subarachnoid haemorrhage and vasospasm: a preliminary study. Acta Neurochir. 2000, 142:83-90.
15. Ostrowski R.P., Colohan A.R., Zhang J.H. Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol. Res. 2006, 28:399-414.
16. Powell J., Kitchen N., Heslin J., Greenwood R. Psychosocial outcomes at 18months after good neurological recovery from aneurysmal subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry 2004, 75:1119-1124.
17. Pradilla G., Wang P.P., Legnani F.G., Ogata L., Dietsch G.N., Tamargo R.J. Prevention of vasospasm by anti-CD11/CD18 monoclonal antibody therapy following subarachnoid hemorrhage in rabbits. J. Neurosurg. 2004, 101:88-92.
18. Provencio J.J., Vora N. Subarachnoid hemorrhage and inflammation: bench to bedside and back. Semin. Neurol. 2005, 25:435-444.
19. Provencio J.J., Fu X., Siu A., Rasmussen P.A., Hazen S.L., Ransohoff R.M. CSF neutrophils are implicated in the development of vasospasm in subarachnoid hemorrhage. Neurocrit. Care 2010, 12:244-251.
20. Pyne-Geithman G.J., Morgan C.J., Wagner K., Dulaney E.M., Carrozzella J., Kanter D.S., Zuccarello M., Clark J.F. Bilirubin production and oxidation in CSF of patients with cerebral vasospasm after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 2005, 25:1070-1077.
21. Shibuya M., Asano T., Sasaki Y. Effect of Fasudil HCl, a protein kinase inhibitor, on cerebral vasospasm. Acta Neurochir. Suppl. 2001, 77:201-204.
22. Takizawa T., Tada T., Kitazawa K., Tanaka Y., Hongo K., Kameko M., Uemura K.I. Inflammatory cytokine cascade released by leukocytes in cerebrospinal fluid after subarachnoid hemorrhage. Neurol. Res. 2001, 23:724-730.
23. Tazawa H., Okada F., Kobayashi T., Tada M., Mori Y., Une Y., Sendo F., Kobayashi M., Hosokawa M. Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression. Am. J. Pathol. 2003, 163:2221-2232.
24. Zubkov A.Y., Tibbs R.E., Aoki K., Zhang J.H. Prevention of vasospasm in penetrating arteries with MAPK inhibitors in dog double-hemorrhage model. Surg. Neurol. 2000, 54:221-227. (discussion 227-8).